Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROTeCt-NEO: Promoting Optimal Treatment Choices Through Implementation of Antibiotic Stewardship Strategies in Neonates With Suspected Early-Onset Sepsis

NCT06845332 is registered in ClinicalTrials.gov with Franciscus Gasthuis as lead sponsor.

NCT NCT06845332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06845332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROTeCt-NEO: Promoting Optimal Treatment Choices Through Implementation of Antibiotic Stewardship Strategies in Neonates With Suspected Early-Onset Sepsis
Lead sponsor
Franciscus Gasthuis
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
June 1, 2026
Enrollment
55,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

early-onset sepsis